| 标题 |
Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Gastroenterology & Hepatology 作者:Jason A Tye-Din; A James M Daveson; Gautam Goel; Kaela E Goldstein; Holly L Hand; et al 出版日期:2023-05-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)